Use of Oral JAK Inhibitors and a TYK2 Inhibitor in the Treatment of Psoriasis–Eczema Overlap ( PsEma ): A Retrospective Study

Documenti analoghi

• Management of Eczematous Reactions Secondary to Biologic Use in Psoriasis Patients: A Retrospective Study
  di: Shivkar Amara, et al.
  Pubblicazione: (2025)
• Real‐World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens
  di: Kateryna Karpoff, et al.
  Pubblicazione: (2026)
• The Role of TYK2 Inhibitors in the Evolving Landscape of Rheumatologic and Dermatologic Treatment
  di: I‐Chang Lai, et al.
  Pubblicazione: (2025)
• Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients With and Without Comorbid Atopic Dermatitis
  di: Jonathan Bar, et al.
  Pubblicazione: (2025)
• Burden of Pain and Use of Analgesics in Patients With Chronic Hand Eczema—Findings From the Danish Skin Cohort
  di: Jeanette Halskou Haugaard, et al.
  Pubblicazione: (2025)